This federal contract award, valued at $1,207.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler (12GM), a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a firm-fixed-price delivery order with an ultimate completion date of August 15, 2024. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,131.32 delivery order contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price pricing type and a completion date of May 1, 2024. Amerisourcebergen holds a...
This federal contract award, valued at $3,348.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication, to DLA Troop Support Medical. This is a Firm Fixed Price delivery order contract, with an ultimate completion date of January 14, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,561.98, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a prescription asthma medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 6, 2024. Amerisourcebergen, a for-profit organization, holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $13,030.44, is for the delivery of Advair HFA 115-21 mcg inhalers. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award, valued at $1,449.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a prescription medication used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 22, 2023. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,612.77, is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of April 30, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
This federal contract award, valued at $5,430.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, with a completion date of January 13, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, worth up to $3,535.36, is a delivery order for the provision of Advair HFA 230-21 mcg inhaler, a prescription drug used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,908.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to support federal healthcare programs. The contract has a completion date of February 5, 2025 and is a firm fixed-price delivery order. Amerisourcebergen also holds a $999,999,999 Indefinite...